We are live on ! Find out more
TBC

Tweedy, Browne Co Portfolio holdings

AUM $1.26B
1-Year Est. Return 33.88%
This Fund
S&P 500
This Quarter Est. Return
+4.5%
1 Year Est. Return
+33.88%
3 Year Est. Return
+71.55%
5 Year Est. Return
+90.93%
10 Year Est. Return
+255.3%
AUM
$1.26B
AUM Growth
+$20.3M
Cap. Flow
-$13.5M
Cap. Flow %
-1.08%
Top 10 Hldgs %
70.33%
Holding
102
New
6
Increased
46
Reduced
30
Closed
9

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$10.5M
2
KT icon
KT
KT
+$1.71M
3
ABG icon
Asbury Automotive
ABG
+$1.61M
4
SNEX icon
StoneX
SNEX
+$1.52M
5
CI icon
Cigna
CI
+$1.49M

Top Sells

Rank Stock Value
1
IONS icon
Ionis Pharmaceuticals
IONS
+$14.9M
2
FDX icon
FedEx
FDX
+$13.4M
3
JNJ icon
Johnson & Johnson
JNJ
+$3.86M
4
WFC icon
Wells Fargo
WFC
+$3.73M
5
BNY
Bank of New York Mellon
BNY
+$2.19M

Sector Composition

Rank Sector Weight
1 Healthcare 25.05%
2 Industrials 24.65%
3 Financials 24%
4 Consumer Staples 10.45%
5 Consumer Discretionary 6.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OBDC icon
101
Blue Owl Capital
OBDC
$5.35B
– –
-70,781
Closed -$880K
1 2 3 4
5

Similar funds

NPT
Nixon Peabody Trust Boston, Massachusetts $1.26B AUM 24.14% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
TWP
Triad Wealth Partners Lawrence, Kansas $1.26B AUM 17.86% 1-Year Est. Return
DAM
Dorsey Asset Management Chicago, Illinois $1.26B AUM 18.46% 1-Year Est. Return
NCM
Novare Capital Management Charlotte, North Carolina $1.26B AUM 20.28% 1-Year Est. Return
PIA
Perennial Investment Advisors Los Angeles, California $1.26B AUM 22.26% 1-Year Est. Return
DP
Dundas Partners Edinburgh, United Kingdom $1.25B AUM 13.92% 1-Year Est. Return
TCA
Teewinot Capital Advisers New York $1.25B AUM 32.55% 1-Year Est. Return

Tweedy, Browne Co's Q1 2026 Portfolio in Review

As of Q1 2026, Tweedy, Browne Co held 102 positions worth $1.26B, up 1.6% from $1.24B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Tweedy, Browne Co's Q1 2026 filing shows 6 new, 46 increased, 30 reduced and 9 closed positions. Its largest new stake was Jazz Pharmaceuticals: 60,209 shares worth $11.4M. The largest sale was Ionis Pharmaceuticals, an estimated $14.9M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Industrials and Financials.

  • Tweedy, Browne Co's largest Q1 2026 buy was Jazz Pharmaceuticals: 60,209 shares worth $11.4M.
  • Tweedy, Browne Co added most to KT in Q1 2026, an estimated $1.71M increase.
  • Tweedy, Browne Co's biggest Q1 2026 reduction was Ionis Pharmaceuticals, cutting an estimated $14.9M.
  • Tweedy, Browne Co fully exited Atmus Filtration Technologies in Q1 2026, selling an estimated $2.1M.
  • Tweedy, Browne Co's ten largest holdings make up 70% of its $1.26B portfolio in Q1 2026.
  • Tweedy, Browne Co opened 6 new positions and closed 9 in Q1 2026.
  • Tweedy, Browne Co's portfolio value rose 1.6% quarter-over-quarter to $1.26B.

Based on Tweedy, Browne Co's 13F filing for Q1 2026, filed 6 May 2026.